Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART

Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART

Related Resources

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

Global Brain Disorders Research

Project Information in NIH RePORTER

Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART

Principal Institution

Stellenbosch University Tygerberg Campus

Principal Investigator(s) (PI)

Decloedt, Eric Hermann; Schifitto, Giovanni

Project Contact Information

Email: ericdecloedt@sun.ac.za

Year(s) Awarded

2021–2023

Country

South Africa

Related World Regions / Countries

Related Global Health Research Topics

  • Neurological and mental disorders and diseases